{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:20:23Z","timestamp":1783675223495,"version":"3.55.0"},"reference-count":195,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,6]]},"abstract":"Abstract<\/jats:title>\n \n Objective<\/jats:title>\n To evaluate physiological and anatomical changes in children with liver cirrhosis supporting the development of physiologically based pharmacokinetic (PBPK) models.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A literature review was conducted (December 2023\u2013May 2024) using PubMed and Google Scholar to identify studies reporting physiological and anatomical parameters in children (<\u200918\u00a0years) with liver cirrhosis. Parameters were analyzed in relation to disease severity (Child\u2013Pugh and\/or MELD\/PELD scores), stratified by age, and compared to adult data. This study examined parameters modified in adult liver cirrhosis PBPK models to assess if similar changes occur in children.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Parameters such as albumin, \u03b11-acid glycoprotein, glomerular filtration rate, functional liver mass, portal blood flow, hepatic arterial blood flow, renal blood flow, and cardiac index showed either comparable alterations or lacked sufficient pediatric data to confirm differences from adult data. Hematocrit was significantly lower in children aged 2 to\u2009<\u20096\u00a0years (\n P<\/jats:italic>\n \u2009=\u20090.022), with up to 25% greater fractional decline compared to adults, possibly due to developmental and nutritional factors.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n While children with liver cirrhosis exhibit physiological trends similar to adults, hematocrit shows a clear age-specific difference. For other parameters, limited pediatric data prevents firm conclusions, highlighting the need for age-specific studies to improve PBPK models and guide pediatric drug therapy.<\/jats:p>\n <\/jats:sec>\n \n Graphical Abstract<\/jats:title>\n \n Key pharmacokinetic alterations in children with liver cirrhosis compared to adults. Created with BioRender.com, incorporating data from Edginton\n et al.<\/jats:italic>\n (2008). Abbreviations:\n CP<\/jats:italic>\n Child\u2013Pugh.\n =<\/jats:sup>\n Parameter is similar as observed in adults.\n \u2260<\/jats:sup>\n Parameter is different as observed in adults.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1007\/s11095-026-04119-y","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T23:04:54Z","timestamp":1779491094000},"page":"1891-1914","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Physiological and Anatomical Alterations in Children with Liver Cirrhosis"],"prefix":"10.1007","volume":"43","author":[{"given":"Femke A.","family":"Elzinga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Lier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R. V.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart L.","family":"Rottier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onno W.","family":"Akkerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henkjan J.","family":"Verkade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bodewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan J.","family":"Touw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Mian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"12","key":"4119_CR1","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","volume":"18","author":"AM Moon","year":"2020","unstructured":"Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020;18(12):2650\u201366. https:\/\/doi.org\/10.1016\/j.cgh.2019.07.060.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"4119_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1046\/j.1440-1746.2002.02678.x","volume":"17","author":"G Arya","year":"2002","unstructured":"Arya G, Balistreri WF. Pediatric liver disease in the United States: epidemiology and impact. J Gastroenterol Hepatol. 2002;17(5):521\u20135. https:\/\/doi.org\/10.1046\/j.1440-1746.2002.02678.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"23","key":"4119_CR3","doi-asserted-by":"publisher","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","volume":"20","author":"WC Zhou","year":"2014","unstructured":"Zhou WC. Pathogenesis of liver cirrhosis. World J Gastroenterol. 2014;20(23):7312. https:\/\/doi.org\/10.3748\/wjg.v20.i23.7312.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"4119_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.18773\/AUSTPRESCR.2021.053","volume":"44","author":"S Gupta","year":"2021","unstructured":"Gupta S, Walker S. Testing for cirrhosis. Aust Prescr. 2021;44(6):197. https:\/\/doi.org\/10.18773\/AUSTPRESCR.2021.053.","journal-title":"Aust Prescr"},{"key":"4119_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.humpath.2019.09.015","volume":"96","author":"MC Olave","year":"2020","unstructured":"Olave MC, Gurung A, Mistry PK, Kakar S, Yeh M, Xu M, et al. Etiology of cirrhosis in the young. Hum Pathol. 2020;96:96\u2013103. https:\/\/doi.org\/10.1016\/j.humpath.2019.09.015.","journal-title":"Hum Pathol"},{"issue":"3","key":"4119_CR6","doi-asserted-by":"publisher","DOI":"10.4254\/WJH.V7.I3.392","volume":"7","author":"RB Pinto","year":"2015","unstructured":"Pinto RB, Schneider ACR, da Silveira TR. Cirrhosis in children and adolescents: an overview. World J Hepatol. 2015;7(3):392. https:\/\/doi.org\/10.4254\/WJH.V7.I3.392.","journal-title":"World J Hepatol"},{"issue":"7","key":"4119_CR7","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s40262-022-01119-0","volume":"61","author":"U Duthaler","year":"2022","unstructured":"Duthaler U, Bachmann F, Suenderhauf C, Grandinetti T, Pfefferkorn F, Haschke M, et al. Liver cirrhosis affects the pharmacokinetics of the six substrates of the Basel phenotyping cocktail differently. Clin Pharmacokinet. 2022;61(7):1039\u201355. https:\/\/doi.org\/10.1007\/s40262-022-01119-0.","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"4119_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/children9071080","volume":"9","author":"R Dobra","year":"2022","unstructured":"Dobra R, Bentley S, Edmondson C, Ovens M, Saunders C, Short C, et al. Going the extra mile: why clinical research in cystic fibrosis must include children. Children Basel. 2022;9(7):1080. https:\/\/doi.org\/10.3390\/children9071080.","journal-title":"Children Basel"},{"issue":"4","key":"4119_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/archdischild-2019-318676","volume":"106","author":"FB Lagler","year":"2021","unstructured":"Lagler FB, Hirschfeld S, Kindblom JM. Challenges in clinical trials for children and young people. Arch Dis Child. 2021;106(4):321\u20135. https:\/\/doi.org\/10.1136\/archdischild-2019-318676.","journal-title":"Arch Dis Child"},{"key":"4119_CR10","unstructured":"European Medicines Agency. European Medicines Agency. Committee for Human Medical Products. Product Information Kaftrio [Internet]. [cited 2025 Jul 11]. Report. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/kaftrio-epar-product-information_en.pdf."},{"issue":"2","key":"4119_CR11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1124\/dmd.112.048504","volume":"41","author":"L De Bock","year":"2013","unstructured":"De Bock L, Boussery K, Van Winckel M, De Paepe P, Rogiers X, Stephenne X, et al. In vitro cytochrome p450 activity decreases in children with high pediatric end-stage liver disease scores. Drug Metab Dispos. 2013;41(2):390\u20137. https:\/\/doi.org\/10.1124\/dmd.112.048504.","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"4119_CR12","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/pan.12995","volume":"26","author":"RN Upton","year":"2016","unstructured":"Upton RN, Foster DJR, Abuhelwa AY. An introduction to physiologically\u2010based pharmacokinetic models. Paediatr Anaesth. 2016;26(11):1036\u201346. https:\/\/doi.org\/10.1111\/pan.12995.","journal-title":"Paediatr Anaesth"},{"issue":"8","key":"4119_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/psp.2013.41","volume":"2","author":"H Jones","year":"2013","unstructured":"Jones H, Rowland\u2010Yeo K. Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development. CPT Pharmacomet Syst Pharmacol. 2013;2(8):1\u201312. https:\/\/doi.org\/10.1038\/psp.2013.41.","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"issue":"10","key":"4119_CR14","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/psp4.12134","volume":"5","author":"L Kuepfer","year":"2016","unstructured":"Kuepfer L, Niederalt C, Wendl T, Schlender JF, Willmann S, Lippert J, et al. Applied concepts in PBPK modeling: how to build a PBPK\/PD model. CPT Pharmacomet Syst Pharmacol. 2016;5(10):516\u201331. https:\/\/doi.org\/10.1002\/psp4.12134.","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"issue":"6","key":"4119_CR15","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/cpt.3032","volume":"114","author":"BG Small","year":"2023","unstructured":"Small BG, Hatley O, Jamei M, Gardner I, Johnson TN. Incorporation and performance verification of hepatic portal blood flow shunting in minimal and full PBPK models of liver cirrhosis. Clin Pharmacol Ther. 2023;114(6):1264\u201373. https:\/\/doi.org\/10.1002\/cpt.3032.","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"4119_CR16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2165\/00003088-200847110-00005","volume":"47","author":"AN Edginton","year":"2008","unstructured":"Edginton AN, Willmann S. Physiology-based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosis. Clin Pharmacokinet. 2008;47(11):743\u201352. https:\/\/doi.org\/10.2165\/00003088-200847110-00005.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"4119_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2165\/11318160-000000000-00000","volume":"49","author":"TN Johnson","year":"2010","unstructured":"Johnson TN, Boussery K, Rowland-Yeo K, Tucker GT, Rostami-Hodjegan A. A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance. Clin Pharmacokinet. 2010;49(3):189\u2013206. https:\/\/doi.org\/10.2165\/11318160-000000000-00000.","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"4119_CR18","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00228-008-0553-z","volume":"64","author":"RK Verbeeck","year":"2008","unstructured":"Verbeeck RK. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol. 2008;64(12):1147\u201361. https:\/\/doi.org\/10.1007\/s00228-008-0553-z.","journal-title":"Eur J Clin Pharmacol"},{"key":"4119_CR19","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.2147\/DDDT.S297981","volume":"15","author":"MN Kalam","year":"2021","unstructured":"Kalam MN, Rasool MF, Alqahtani F, Imran I, Rehman AU, Ahmed N. Development and evaluation of a physiologically based pharmacokinetic drug-disease model of Propranolol for suggesting model informed dosing in liver cirrhosis patients. Drug Des Devel Ther. 2021;15:1195\u2013211. https:\/\/doi.org\/10.2147\/DDDT.S297981.","journal-title":"Drug Des Devel Ther"},{"key":"4119_CR20","unstructured":"Google Scholar [Internet]. Available from: https:\/\/scholar.google.com\/.\u00a0Accessed 1 Dec 2023."},{"key":"4119_CR21","unstructured":"National Library of Medicine. PubMed [Internet]. Available from:\u00a0\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/. Accessed 1 Dec 2023."},{"issue":"4","key":"4119_CR22","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/bcp.15990","volume":"90","author":"S Armani","year":"2024","unstructured":"Armani S, Geier A, Forst T, Merle U, Alpers DH, Lunnon MW. Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: impact on pharmacokinetics and drug\u2013drug interactions. Br J Clin Pharmacol. 2024;90(4):942\u201358. https:\/\/doi.org\/10.1111\/bcp.15990.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"4119_CR23","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1021\/acs.molpharmaceut.1c00462","volume":"18","author":"E El-Khateeb","year":"2021","unstructured":"El-Khateeb E, Achour B, Al-Majdoub ZM, Barber J, Rostami-Hodjegan A. Non-uniformity of changes in drug-metabolizing enzymes and transporters in liver cirrhosis: implications for drug dosage adjustment. Mol Pharm. 2021;18(9):3563\u201377. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.1c00462.","journal-title":"Mol Pharm"},{"issue":"Supplement_3","key":"4119_CR24","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1542\/peds.2012-0055I","volume":"129","author":"K Williams","year":"2012","unstructured":"Williams K, Thomson D, Seto I, Contopoulos-Ioannidis DG, Ioannidis JPA, Curtis S, et al. Standard 6: age groups for pediatric trials. Pediatrics. 2012;129(Supplement_3):S153-60. https:\/\/doi.org\/10.1542\/peds.2012-0055I.","journal-title":"Pediatrics"},{"issue":"20","key":"4119_CR25","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i20.3099","volume":"11","author":"GV Papatheodoridis","year":"2005","unstructured":"Papatheodoridis GV. MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis. World J Gastroenterol. 2005;11(20):3099. https:\/\/doi.org\/10.3748\/wjg.v11.i20.3099.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"4119_CR26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3748\/wjg.14.286","volume":"14","author":"KA Attia","year":"2008","unstructured":"Attia KA, Ackoundou-N\u2019guessan KC, N\u2019dri-Yoman AT, Mahassadi AK, Messou E, Bathaix YF, et al. Child-Pugh-Turcott versus MELD score for predicting survival in a retrospective cohort of black African cirrhotic patients. World J Gastroenterol. 2008;14(2):286\u201391. https:\/\/doi.org\/10.3748\/wjg.14.286.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"4119_CR27","doi-asserted-by":"publisher","first-page":"724","DOI":"10.2298\/vsp0909724b","volume":"66","author":"D Benedeto-Stojanov","year":"2009","unstructured":"Benedeto-Stojanov D, Nagorni A, Bjelakovi\u0107 G, Stojanov D, Mladenovi\u0107 B, Djeni\u0107 N. The model for the end-stage liver disease and Child-Pugh score in predicting prognosis in patients with liver cirrhosis and esophageal variceal bleeding. Vojnosanit Pregl. 2009;66(9):724\u20138. https:\/\/doi.org\/10.2298\/vsp0909724b.","journal-title":"Vojnosanit Pregl"},{"issue":"3","key":"4119_CR28","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S1665-2681(19)31853-8","volume":"7","author":"AR Flores-Rend\u00f3n","year":"2008","unstructured":"Flores-Rend\u00f3n AR, Gonz\u00e1lez-Gonz\u00e1lez JA, Garc\u00eda-Compean D, Maldonado-Garza HJ, Garza-Galindo AA. Model for end stage of liver disease (MELD) is better than the Child-Pugh score for predicting in-hospital mortality related to esophageal variceal bleeding. Ann Hepatol. 2008;7(3):230\u20134.","journal-title":"Ann Hepatol"},{"issue":"5","key":"4119_CR29","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3748\/wjg.v27.i5.416","volume":"27","author":"Z Wang","year":"2021","unstructured":"Wang Z, Wu YF, Yue ZD, Zhao HW, Wang L, Fan ZH, et al. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. World J Gastroenterol. 2021;27(5):416\u201327. https:\/\/doi.org\/10.3748\/wjg.v27.i5.416.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"4119_CR30","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/j.1572-0241.2003.07515.x","volume":"98","author":"M Schepke","year":"2003","unstructured":"Schepke M, Roth F, Fimmers R, Brensing KA, Sudhop T, Schild HH, et al. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol. 2003;98(5):1167\u201374. https:\/\/doi.org\/10.1111\/j.1572-0241.2003.07515.x.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"4119_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/gut.52.1.134","volume":"52","author":"F Botta","year":"2003","unstructured":"Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut. 2003;52(1):134\u20139. https:\/\/doi.org\/10.1136\/gut.52.1.134.","journal-title":"Gut"},{"issue":"1","key":"4119_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/gast.2003.50016","volume":"124","author":"R Wiesner","year":"2003","unstructured":"Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124(1):91\u20136. https:\/\/doi.org\/10.1053\/gast.2003.50016.","journal-title":"Gastroenterology"},{"issue":"1","key":"4119_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00147-003-0655-6","volume":"17","author":"D Degr\u00e9","year":"2004","unstructured":"Degr\u00e9 D, Bourgeois N, Boon N, Le Moine O, Louis H, Donckier V, et al. Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation. Transpl Int. 2004;17(1):31\u20138. https:\/\/doi.org\/10.1007\/s00147-003-0655-6.","journal-title":"Transpl Int"},{"issue":"6","key":"4119_CR34","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.jhep.2004.02.010","volume":"40","author":"A Said","year":"2004","unstructured":"Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol. 2004;40(6):897\u2013903. https:\/\/doi.org\/10.1016\/j.jhep.2004.02.010.","journal-title":"J Hepatol"},{"issue":"3","key":"4119_CR35","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jhep.2017.10.001","volume":"68","author":"R Bolia","year":"2018","unstructured":"Bolia R, Srivastava A, Yachha SK, Poddar U. Pediatric CLIF-SOFA score is the best predictor of 28-day mortality in children with decompensated chronic liver disease. J Hepatol. 2018;68(3):449\u201355. https:\/\/doi.org\/10.1016\/j.jhep.2017.10.001.","journal-title":"J Hepatol"},{"issue":"1","key":"4119_CR36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5009\/gnl.2012.6.1.92","volume":"6","author":"M Cakir","year":"2012","unstructured":"Cakir M, Karahan SC, Mentese A, Sag E, Cobanoglu U, Polat TB, et al. Ischemia-modified albumin levels in children with chronic liver disease. Gut Liver. 2012;6(1):92\u20137. https:\/\/doi.org\/10.5009\/gnl.2012.6.1.92.","journal-title":"Gut Liver"},{"issue":"1","key":"4119_CR37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.14309\/ajg.0000000000001486","volume":"117","author":"PR Tripathi","year":"2022","unstructured":"Tripathi PR, Sen Sarma M, Yachha SK, Aggarwal A, Bhatia V, Kumar A, et al. Relative adrenal insufficiency in decompensated cirrhotic children: does it affect outcome? Am J Gastroenterol. 2022;117(1):120\u20138. https:\/\/doi.org\/10.14309\/ajg.0000000000001486.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"4119_CR38","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00540-010-0928-z","volume":"24","author":"I Alper","year":"2010","unstructured":"Alper I, Ulukaya S. Anesthetic management in pediatric liver transplantation: a comparison of deceased or live donor liver transplantations. J Anesth. 2010;24(3):399\u2013406. https:\/\/doi.org\/10.1007\/s00540-010-0928-z.","journal-title":"J Anesth"},{"issue":"10","key":"4119_CR39","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1016\/j.transproceed.2007.07.080","volume":"39","author":"SM Dehghani","year":"2007","unstructured":"Dehghani SM, Gholami S, Bahador A, Haghighat M, Imanieh MH, Nikeghbalian S, et al. Comparison of Child-Turcotte-Pugh and pediatric end-stage liver disease scoring systems to predict morbidity and mortality of children awaiting liver transplantation. Transplant Proc. 2007;39(10):3175\u20137. https:\/\/doi.org\/10.1016\/j.transproceed.2007.07.080.","journal-title":"Transplant Proc"},{"issue":"5","key":"4119_CR40","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1517\/17425247.2015.993313","volume":"12","author":"D Sleep","year":"2015","unstructured":"Sleep D. Albumin and its application in drug delivery. Expert Opin Drug Deliv. 2015;12(5):793\u2013812. https:\/\/doi.org\/10.1517\/17425247.2015.993313.","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"4119_CR41","first-page":"301","volume":"82","author":"G Zaccherini","year":"2019","unstructured":"Zaccherini G, Bernardi M. The role and indications of albumin in advanced liver disease. Acta Gastroenterol Belg. 2019;82(2):301\u20138.","journal-title":"Acta Gastroenterol Belg"},{"issue":"Suppl 1","key":"4119_CR42","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/S1665-2681(19)31600-X","volume":"10","author":"V Arroyo","year":"2011","unstructured":"Arroyo V, Fernandez J. Pathophysiological basis of albumin use in cirrhosis. Ann Hepatol. 2011;10(Suppl 1):S6-14.","journal-title":"Ann Hepatol"},{"key":"4119_CR43","doi-asserted-by":"publisher","unstructured":"Suchy FJ, SRJ, BWF, BJA, MCL, & SBL. Liver disease in children. 5th ed. In: Suchy FJ, RJS, WFBEds, editors. Cambridge University Press; 2021. https:\/\/doi.org\/10.1017\/9781108918978.","DOI":"10.1017\/9781108918978"},{"issue":"4","key":"4119_CR44","first-page":"128","volume":"30","author":"A Viani","year":"1992","unstructured":"Viani A, Rizzo G, Carrai M, Pacifici GM. Interindividual variability in the concentrations of albumin and alpha-1-acid glycoprotein in patients with renal or liver disease, newborns and healthy subjects: implications for binding of drugs. Int J Clin Pharmacol. 1992;30(4):128\u201333.","journal-title":"Int J Clin Pharmacol"},{"issue":"3","key":"4119_CR45","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/clpt.1990.41","volume":"47","author":"M Barry","year":"1990","unstructured":"Barry M, Keeling PW, Weir D, Feely J. Severity of cirrhosis and the relationship of \u03b11-acid glycoprotein concentration to plasma protein binding of lidocaine. Clin Pharmacol Ther. 1990;47(3):366\u201370. https:\/\/doi.org\/10.1038\/clpt.1990.41.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"4119_CR46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00007691-198609000-00003","volume":"8","author":"GM Pacifici","year":"1986","unstructured":"Pacifici GM, Viani A, Taddeucci-Brunelli G, Rizzo G, Carrai M, Schulz HU. Effects of development, aging, and renal and hepatic insufficiency as well as hemodialysis on the plasma concentrations of albumin and alpha 1-acid glycoprotein: implications for binding of drugs. Ther Drug Monit. 1986;8(3):259\u201363. https:\/\/doi.org\/10.1097\/00007691-198609000-00003.","journal-title":"Ther Drug Monit"},{"issue":"8","key":"4119_CR47","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1016\/J.XPHS.2019.03.018","volume":"108","author":"PJ McNamara","year":"2019","unstructured":"McNamara PJ, Meiman D. Predicting drug binding to Human Serum Albumin and Alpha One Acid Glycoprotein in diseased and age patient populations. J Pharm Sci. 2019;108(8):2737\u201347. https:\/\/doi.org\/10.1016\/J.XPHS.2019.03.018.","journal-title":"J Pharm Sci"},{"issue":"7","key":"4119_CR48","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/j.xphs.2018.02.021","volume":"107","author":"GF Li","year":"2018","unstructured":"Li GF, Yu G, Li Y, Zheng Y, Zheng QS, Derendorf H. Quantitative estimation of plasma free drug fraction in patients with varying degrees of hepatic impairment: a methodological evaluation. J Pharm Sci. 2018;107(7):1948\u201356. https:\/\/doi.org\/10.1016\/j.xphs.2018.02.021.","journal-title":"J Pharm Sci"},{"issue":"3","key":"4119_CR49","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/00000542-199003000-00013","volume":"72","author":"C Meistelman","year":"1990","unstructured":"Meistelman C, Benhamou D, Barre J, Levron JC, Mahe V, Mazoit X, et al. Effects of age on plasma protein binding of sufentanil. Anesthesiology. 1990;72(3):470\u20133. https:\/\/doi.org\/10.1097\/00000542-199003000-00013.","journal-title":"Anesthesiology"},{"issue":"45","key":"4119_CR50","doi-asserted-by":"publisher","first-page":"7739","DOI":"10.3748\/wjg.v27.i45.7739","volume":"27","author":"GO Elpek","year":"2021","unstructured":"Elpek GO. Orosomucoid in liver diseases. World J Gastroenterol. 2021;27(45):7739\u201347. https:\/\/doi.org\/10.3748\/wjg.v27.i45.7739.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4119_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1460-9592.1993.tb00028.x","volume":"3","author":"PJ Davis","year":"1993","unstructured":"Davis PJ, Stiller RL, McGOWAN FX, Chakravorti S, Cook DR. Decreased protein binding of alfentanil in plasma from children with kidney or liver failure. Paediatr Anaesth. 1993;3(1):19\u201322. https:\/\/doi.org\/10.1111\/j.1460-9592.1993.tb00028.x.","journal-title":"Paediatr Anaesth"},{"issue":"402","key":"4119_CR52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF02753434","volume":"50","author":"SC Vij","year":"1983","unstructured":"Vij SC, Bhardwaj SD, Mathur HC, Raghav M. Serum glycoproteins in infantile cirrhosis of liver. Indian J Pediatr. 1983;50(402):17\u201320. https:\/\/doi.org\/10.1007\/BF02753434.","journal-title":"Indian J Pediatr"},{"key":"4119_CR53","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.1093\/med\/9780199204854.003.220505_update_001","volume":"24","author":"G Yilmaz","year":"2023","unstructured":"Yilmaz G, Shaikh H. Normochromic Normocytic Anemia. Oxford Textbook of Medicine. 2023;24:4400\u20132. https:\/\/doi.org\/10.1093\/med\/9780199204854.003.220505_update_001.","journal-title":"Oxford Textbook of Medicine"},{"issue":"5","key":"4119_CR54","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1440-1746.2006.04266.x","volume":"21","author":"TT Liu","year":"2006","unstructured":"Liu TT, Wong WJ, Hou MC, Lin HC, Chang FY, Lee SD. Hemorheology in patients with liver cirrhosis: special emphasis on its relation to severity of esophageal variceal bleeding. J Gastroenterol Hepatol. 2006;21(5):908\u201313. https:\/\/doi.org\/10.1111\/j.1440-1746.2006.04266.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"4119_CR55","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1067\/mlc.2001.119106","volume":"138","author":"S Maruyama","year":"2001","unstructured":"Maruyama S, Hirayama C, Yamamoto S, Koda M, Udagawa A, Kadowaki Y, et al. Red blood cell status in alcoholic and non-alcoholic liver disease. J Lab Clin Med. 2001;138(5):332\u20137. https:\/\/doi.org\/10.1067\/mlc.2001.119106.","journal-title":"J Lab Clin Med"},{"issue":"5","key":"4119_CR56","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/BF02347621","volume":"31","author":"M Toyota","year":"1996","unstructured":"Toyota M, Hinoda Y, Nakagawa N, Arimura Y, Tokuchi S, Takaoka A, et al. Gastric antral vascular ectasia causing severe anemia. J Gastroenterol. 1996;31(5):710\u20133. https:\/\/doi.org\/10.1007\/BF02347621.","journal-title":"J Gastroenterol"},{"issue":"3","key":"4119_CR57","doi-asserted-by":"publisher","first-page":"777","DOI":"10.12998\/WJCC.V10.I3.777","volume":"10","author":"M Manrai","year":"2022","unstructured":"Manrai M, Dawra S, Srivastava S, Kapoor R, Singh A. Anemia in cirrhosis: an underestimated entity. World J Clin Cases. 2022;10(3):777\u201389. https:\/\/doi.org\/10.12998\/WJCC.V10.I3.777.","journal-title":"World J Clin Cases"},{"issue":"7","key":"4119_CR58","doi-asserted-by":"publisher","first-page":"795","DOI":"10.4155\/TDE.15.34","volume":"6","author":"CH Villa","year":"2015","unstructured":"Villa CH, Pan DC, Zaitsev S, Cines DB, Siegel DL, Muzykantov VR. Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier. Ther Deliv. 2015;6(7):795. https:\/\/doi.org\/10.4155\/TDE.15.34.","journal-title":"Ther Deliv"},{"issue":"2","key":"4119_CR59","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1172\/JCI115619","volume":"89","author":"BS Coller","year":"1992","unstructured":"Coller BS, Springer KT, Beer JH, Mohandas N, Scudder LE, Norton KJ, et al. Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions. J Clin Invest. 1992;89(2):546\u201355. https:\/\/doi.org\/10.1172\/JCI115619.","journal-title":"J Clin Invest"},{"issue":"1","key":"4119_CR60","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1073\/pnas.76.1.473","volume":"76","author":"GL Dale","year":"1979","unstructured":"Dale GL, Kuhl W, Beutler E. Incorporation of glucocerebrosidase into Gaucher\u2019s disease monocytes in vitro. Proc Natl Acad Sci U S A. 1979;76(1):473\u20135. https:\/\/doi.org\/10.1073\/pnas.76.1.473.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"4119_CR61","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0304-4165(86)90184-4","volume":"884","author":"VR Muzykantov","year":"1986","unstructured":"Muzykantov VR, Sakharov DV, Smirnov MD, Samokhin GP, Smirnov VN. Immunotargeting of erythrocytes-bound streptokinase provides local lysis of a fibrin clot. Biochim Biophys Acta. 1986;884(2):355\u201362. https:\/\/doi.org\/10.1016\/0304-4165(86)90184-4.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"4119_CR62","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/00005176-199610000-00002","volume":"23","author":"VL Fox","year":"1996","unstructured":"Fox VL, Cohen MB, Whitington PF, Colletti RB. Outpatient liver biopsy in children: a medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr. 1996;23(3):213\u20136. https:\/\/doi.org\/10.1097\/00005176-199610000-00002.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"4119_CR63","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1542\/peds.52.3.388","volume":"52","author":"WA Daniel","year":"1973","unstructured":"Daniel WA. Hematocrit: maturity relationship in adolescence. Pediatrics. 1973;52(3):388\u201394.","journal-title":"Pediatrics"},{"issue":"8","key":"4119_CR64","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1373\/clinchem.2015.240531","volume":"61","author":"K Adeli","year":"2015","unstructured":"Adeli K, Raizman JE, Chen Y, Higgins V, Nieuwesteeg M, Abdelhaleem M, et al. Complex biological profile of hematologic markers across pediatric, adult, and geriatric ages: establishment of robust pediatric and adult reference intervals on the basis of the Canadian Health Measures Survey. Clin Chem. 2015;61(8):1075\u201386. https:\/\/doi.org\/10.1373\/clinchem.2015.240531.","journal-title":"Clin Chem"},{"issue":"4","key":"4119_CR65","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/MPG.0000000000003555","volume":"75","author":"C Jarasvaraparn","year":"2022","unstructured":"Jarasvaraparn C, Rusch C, Nadler M, Drobish J, Stoll J, Doyle MB, et al. Characterization of biomarkers of hemostasis and bleeding-related outcomes in children with cirrhosis. J Pediatr Gastroenterol Nutr. 2022;75(4):506\u201313. https:\/\/doi.org\/10.1097\/MPG.0000000000003555.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4119_CR66","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.regpep.2012.10.004","volume":"180","author":"CTL Dornelles","year":"2013","unstructured":"Dornelles CTL, Goldani HAS, Wilasco MIA, Maurer RL, Kieling CO, Porowski M, et al. Ghrelin, leptin and insulin in cirrhotic children and adolescents: relationship with cirrhosis severity and nutritional status. Regul Pept. 2013;180:26\u201332. https:\/\/doi.org\/10.1016\/j.regpep.2012.10.004.","journal-title":"Regul Pept"},{"issue":"10","key":"4119_CR67","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1016\/j.transproceed.2018.05.025","volume":"50","author":"VP Mali","year":"2018","unstructured":"Mali VP, Fukuda A, Shigeta T, Uchida H, Kanazawa H, Hirata Y, et al. Mild to moderate intrapulmonary shunting in pediatric liver transplantation: is screening necessary? Transplant Proc. 2018;50(10):3496\u2013500. https:\/\/doi.org\/10.1016\/j.transproceed.2018.05.025.","journal-title":"Transplant Proc"},{"issue":"1","key":"4119_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000447364","volume":"69","author":"MIA Wilasco","year":"2016","unstructured":"Wilasco MIA, Uribe-Cruz C, Santetti D, Pfaffenseller B, Dornelles CTL, da Silveira TR. Brain-derived neurotrophic factor in children and adolescents with cirrhosis due to biliary atresia. Ann Nutr Metab. 2016;69(1):1\u20138. https:\/\/doi.org\/10.1159\/000447364.","journal-title":"Ann Nutr Metab"},{"key":"4119_CR69","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14131","author":"C Jarasvaraparn","year":"2022","unstructured":"Jarasvaraparn C, Choudhury S, Rusch C, Nadler M, Liss KHH, Stoll J, et al. Characteristics, risk factors, and outcomes of neutropenia after liver or kidney transplantation in children. Pediatr Transplant. 2022. https:\/\/doi.org\/10.1111\/petr.14131.","journal-title":"Pediatr Transplant"},{"issue":"10","key":"4119_CR70","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1007\/s13312-022-2622-2","volume":"59","author":"J Chandra","year":"2022","unstructured":"Chandra J, Dewan P, Kumar P, Mahajan A, Singh P, Dhingra B, et al. Diagnosis, treatment and prevention of nutritional anemia in children: recommendations of the Joint Committee of Pediatric Hematology-Oncology Chapter and Pediatric and Adolescent Nutrition Society of the Indian Academy of Pediatrics. Indian Pediatr. 2022;59(10):782\u2013801.","journal-title":"Indian Pediatr"},{"issue":"7","key":"4119_CR71","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.2215\/CJN.00340118","volume":"13","author":"TN Lea-Henry","year":"2018","unstructured":"Lea-Henry TN, Carland JE, Stocker SL, Sevastos J, Roberts DM. Clinical pharmacokinetics in kidney disease: fundamental principles. Clin J Am Soc Nephrol. 2018;13(7):1085\u201395. https:\/\/doi.org\/10.2215\/CJN.00340118.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"4119_CR72","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00467-008-0997-5","volume":"24","author":"MM Rhodin","year":"2009","unstructured":"Rhodin MM, Anderson BJ, Peters AM, Coulthard MG, Wilkins B, Cole M, et al. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol. 2009;24(1):67\u201376. https:\/\/doi.org\/10.1007\/s00467-008-0997-5.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"4119_CR73","first-page":"11","volume":"28","author":"CKF Ng","year":"2007","unstructured":"Ng CKF, Chan MHM, Tai MHL, Lam CWK. Hepatorenal syndrome. Clin Biochem Rev. 2007;28(1):11\u20137.","journal-title":"Clin Biochem Rev"},{"key":"4119_CR74","unstructured":"Girish V, Ranasinghe IR, Rout P. Hepatorenal Syndrome. StatPearls Publishing; 2026."},{"issue":"3","key":"4119_CR75","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/MPG.0000000000003522","volume":"75","author":"K Black","year":"2022","unstructured":"Black K, Ziogas IA, Thurm C, Hall M, Hafberg E, Alexopoulos SP, et al. Pediatric liver transplant survival in Alagille syndrome is comparable to biliary atresia-a linked database analysis. J Pediatr Gastroenterol Nutr. 2022;75(3):257\u201363. https:\/\/doi.org\/10.1097\/MPG.0000000000003522.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"12","key":"4119_CR76","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1111\/j.1600-6143.2012.04270.x","volume":"12","author":"RL Ruebner","year":"2012","unstructured":"Ruebner RL, Reese PP, Denburg MR, Rand EB, Abt PL, Furth SL. Risk factors for end-stage kidney disease after pediatric liver transplantation. Am J Transplant. 2012;12(12):3398\u2013405. https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04270.x.","journal-title":"Am J Transplant"},{"issue":"8","key":"4119_CR77","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13579","volume":"23","author":"JJ Valamparampil","year":"2019","unstructured":"Valamparampil JJ, Reddy MS, Shanmugam N, Vij M, Kanagavelu RG, Rela M. Living donor liver transplantation in Alagille syndrome-single center experience from South Asia. Pediatr Transplant. 2019;23(8):e13579. https:\/\/doi.org\/10.1111\/petr.13579.","journal-title":"Pediatr Transplant"},{"issue":"7","key":"4119_CR78","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1097\/TP.0000000000004465","volume":"107","author":"K Umemura","year":"2023","unstructured":"Umemura K, Mita A, Ohno Y, Masuda Y, Yoshizawa K, Kubota K, et al. Late-onset chronic kidney disease over 2 decades after pediatric liver transplantation: a single-center, retrospective study. Transplantation. 2023;107(7):1535\u201344. https:\/\/doi.org\/10.1097\/TP.0000000000004465.","journal-title":"Transplantation"},{"issue":"11","key":"4119_CR79","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1111\/j.1600-6143.2006.01528.x","volume":"6","author":"CL Chen","year":"2006","unstructured":"Chen CL, Concejero A, Wang CC, Wang SH, Lin CC, Liu YW, et al. Living donor liver transplantation for biliary atresia: a single-center experience with first 100 cases. Am J Transplant. 2006;6(11):2672\u20139. https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01528.x.","journal-title":"Am J Transplant"},{"issue":"1","key":"4119_CR80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/hepr.13847","volume":"53","author":"RV Yewale","year":"2023","unstructured":"Yewale RV, Ramakrishna BS. Novel biomarkers of acute kidney injury in chronic liver disease: where do we stand after a decade of research? Hepatol Res. 2023;53(1):3\u201317. https:\/\/doi.org\/10.1111\/hepr.13847.","journal-title":"Hepatol Res"},{"key":"4119_CR81","unstructured":"Drugs and the liver: Metabolism and mechanisms of injury - UpToDate [Internet]. [cited 2024 Dec 18]. Available from: https:\/\/www.uptodate.com\/contents\/drugs-and-the-liver-metabolism-and-mechanisms-of-injury."},{"issue":"4","key":"4119_CR82","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11684-012-0223-5","volume":"6","author":"C Tong","year":"2012","unstructured":"Tong C, Xu X, Liu C, Zhang T, Qu K. Assessment of liver volume variation to evaluate liver function. Front Med. 2012;6(4):421\u20137. https:\/\/doi.org\/10.1007\/s11684-012-0223-5.","journal-title":"Front Med"},{"issue":"5","key":"4119_CR83","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.2214\/ajr.173.5.10541086","volume":"173","author":"GD Dodd","year":"1999","unstructured":"Dodd GD, Baron RL, Oliver JH, Federle MP. Spectrum of imaging findings of the liver in end-stage cirrhosis: Part II, focal abnormalities. AJR Am J Roentgenol. 1999;173(5):1185\u201392. https:\/\/doi.org\/10.2214\/ajr.173.5.10541086.","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"4119_CR84","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00535-009-0017-y","volume":"44","author":"JH Wang","year":"2009","unstructured":"Wang JH, Changchien CS, Hung CH, Eng HL, Tung WC, Kee KM, et al. FibroScan and ultrasonography in the prediction of hepatic fibrosis in patients with chronic viral hepatitis. J Gastroenterol. 2009;44(5):439\u201346. https:\/\/doi.org\/10.1007\/s00535-009-0017-y.","journal-title":"J Gastroenterol"},{"issue":"4","key":"4119_CR85","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3348\/kjr.2011.12.4.431","volume":"12","author":"JH Shim","year":"2011","unstructured":"Shim JH, Yu JS, Chung JJ, Kim JH, Kim KW. Segmental difference of the hepatic fibrosis from chronic viral hepatitis due to Hepatitis B versus C virus infection: comparison using dual contrast material-enhanced MRI. Korean J Radiol. 2011;12(4):431\u20138. https:\/\/doi.org\/10.3348\/kjr.2011.12.4.431.","journal-title":"Korean J Radiol"},{"issue":"2","key":"4119_CR86","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/00004728-200003000-00002","volume":"24","author":"GA Krinsky","year":"2000","unstructured":"Krinsky GA, Lee VS, Theise ND. Focal lesions in the cirrhotic liver: high resolution ex vivo MRI with pathologic correlation. J Comput Assist Tomogr. 2000;24(2):189\u201396. https:\/\/doi.org\/10.1097\/00004728-200003000-00002.","journal-title":"J Comput Assist Tomogr"},{"issue":"12","key":"4119_CR87","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/lt.20519","volume":"11","author":"TN Johnson","year":"2005","unstructured":"Johnson TN, Tucker GT, Tanner MS, Rostami-Hodjegan A. Changes in liver volume from birth to adulthood: a meta-analysis. Liver Transpl. 2005;11(12):1481\u201393. https:\/\/doi.org\/10.1002\/lt.20519.","journal-title":"Liver Transpl"},{"issue":"10059","key":"4119_CR88","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","volume":"388","author":"JS Elborn","year":"2016","unstructured":"Elborn JS. Cystic fibrosis. Lancet. 2016;388(10059):2519\u201331. https:\/\/doi.org\/10.1016\/S0140-6736(16)00576-6.","journal-title":"Lancet"},{"key":"4119_CR89","doi-asserted-by":"publisher","unstructured":"Kang Y, Elia E. Anesthesia management of liver transplantation. Contemporary liver transplantation. 2017;143. https:\/\/doi.org\/10.1007\/978-3-319-07209-8_9.","DOI":"10.1007\/978-3-319-07209-8_9"},{"key":"4119_CR90","doi-asserted-by":"publisher","unstructured":"Horslen S. Phenotypes of liver diseases in infants, children, and adolescents. Dis Liver in Child. 2014;9781461490050:107.https:\/\/doi.org\/10.1007\/978-1-4614-9005-0_6.","DOI":"10.1007\/978-1-4614-9005-0_6"},{"issue":"5","key":"4119_CR91","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/s0022-3476(49)80285-x","volume":"34","author":"PD Keller","year":"1949","unstructured":"Keller PD, Nute WL. Cirrhosis of the liver in children; a clinical and pathologic study of 40 cases. J Pediatr. 1949;34(5):588\u2013615. https:\/\/doi.org\/10.1016\/s0022-3476(49)80285-x.","journal-title":"J Pediatr"},{"issue":"6","key":"4119_CR92","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00006231-199106000-00005","volume":"12","author":"I Virgolini","year":"1991","unstructured":"Virgolini I, M\u00fcller C, Angelberger P, H\u00f6bart J, Bergmann H, Sinzinger H. Functional liver imaging with 99Tcm-galactosyl-neoglycoalbumin (NGA) in alcoholic liver cirrhosis and liver fibrosis. Nucl Med Commun. 1991;12(6):507\u201317. https:\/\/doi.org\/10.1097\/00006231-199106000-00005.","journal-title":"Nucl Med Commun"},{"issue":"9","key":"4119_CR93","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.3748\/wjg.v9.i9.2092","volume":"9","author":"YM Li","year":"2003","unstructured":"Li YM, Lv F, Xu X, Ji H, Gao WT, Lei TJ. Evaluation of liver functional reserve by combining D-sorbitol clearance rate and CT measured liver volume. World J Gastroenterol. 2003;9(9):2092\u20135. https:\/\/doi.org\/10.3748\/wjg.v9.i9.2092.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"4119_CR94","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1572-0241.2001.03556.x","volume":"96","author":"AH Kwon","year":"2001","unstructured":"Kwon AH, Matsui Y, Ha-Kawa SK, Kamiyama Y. Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography. Am J Gastroenterol. 2001;96(2):541\u20136. https:\/\/doi.org\/10.1111\/j.1572-0241.2001.03556.x.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"4119_CR95","first-page":"733","volume":"42","author":"K Miki","year":"2001","unstructured":"Miki K, Kubota K, Inoue Y, Vera DR, Makuuchi M. Receptor measurements via Tc-GSA kinetic modeling are proportional to functional hepatocellular mass. J Nucl Med. 2001;42(5):733\u20137.","journal-title":"J Nucl Med"},{"issue":"22","key":"4119_CR96","first-page":"1069","volume":"45","author":"XZ Lin","year":"1998","unstructured":"Lin XZ, Sun YN, Liu YH, Sheu BS, Cheng BN, Chen CY, et al. Liver volume in patients with or without chronic liver diseases. Hepatogastroenterology. 1998;45(22):1069\u201374.","journal-title":"Hepatogastroenterology"},{"issue":"5","key":"4119_CR97","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.transproceed.2018.01.052","volume":"50","author":"N Okada","year":"2018","unstructured":"Okada N, Sanada Y, Urahashi T, Ihara Y, Yamada N, Hirata Y, et al. Endotoxin metabolism reflects hepatic functional reserve in end-stage liver disease. Transplant Proc. 2018;50(5):1360\u20134. https:\/\/doi.org\/10.1016\/j.transproceed.2018.01.052.","journal-title":"Transplant Proc"},{"issue":"1","key":"4119_CR98","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","volume":"60","author":"R Wiest","year":"2014","unstructured":"Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2014;60(1):197\u2013209. https:\/\/doi.org\/10.1016\/j.jhep.2013.07.044.","journal-title":"J Hepatol"},{"issue":"45","key":"4119_CR99","doi-asserted-by":"publisher","first-page":"16795","DOI":"10.3748\/wjg.v20.i45.16795","volume":"20","author":"V Giannelli","year":"2014","unstructured":"Giannelli V, Di Gregorio V, Iebba V, Giusto M, Schippa S, Merli M. Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis. World J Gastroenterol. 2014;20(45):16795\u2013810. https:\/\/doi.org\/10.3748\/wjg.v20.i45.16795.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"4119_CR100","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s12072-011-9289-4","volume":"6","author":"Y Sanada","year":"2012","unstructured":"Sanada Y, Mizuta K, Urahashi T, Ihara Y, Wakiya T, Okada N, et al. Impact of hepatic clearance of endotoxin using endotoxin activity assay. Hepatol Int. 2012;6(4):778\u201382. https:\/\/doi.org\/10.1007\/s12072-011-9289-4.","journal-title":"Hepatol Int"},{"issue":"2","key":"4119_CR101","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jss.2012.05.004","volume":"180","author":"Y Sanada","year":"2013","unstructured":"Sanada Y, Mizuta K, Urahashi T, Ihara Y, Wakiya T, Okada N, et al. Impact of endotoxin measured by an endotoxin activity assay during liver transplantation. J Surg Res. 2013;180(2):349\u201355. https:\/\/doi.org\/10.1016\/j.jss.2012.05.004.","journal-title":"J Surg Res"},{"issue":"2","key":"4119_CR102","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/hepr.13249","volume":"49","author":"Y Okura","year":"2019","unstructured":"Okura Y, Namisaki T, Sato S, Moriya K, Akahane T, Kitade M, et al. Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosis. Hepatol Res. 2019;49(2):232\u20138. https:\/\/doi.org\/10.1111\/hepr.13249.","journal-title":"Hepatol Res"},{"issue":"10","key":"4119_CR103","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00383-012-3166-7","volume":"28","author":"Y Sanada","year":"2012","unstructured":"Sanada Y, Mizuta K, Urahashi T, Ihara Y, Wakiya T, Okada N, et al. The efficacy of measurement of the serum beta-D glucan in the patients with biliary atresia. Pediatr Surg Int. 2012;28(10):993\u20136. https:\/\/doi.org\/10.1007\/s00383-012-3166-7.","journal-title":"Pediatr Surg Int"},{"issue":"9","key":"4119_CR104","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3109\/00365529709011206","volume":"32","author":"CC Chan","year":"1997","unstructured":"Chan CC, Hwang SJ, Lee FY, Wang SS, Chang FY, Li CP, et al. Prognostic value of plasma endotoxin levels in patients with cirrhosis. Scand J Gastroenterol. 1997;32(9):942\u20136. https:\/\/doi.org\/10.3109\/00365529709011206.","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"4119_CR105","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1007\/BF00311454","volume":"25","author":"Y Kimura","year":"1995","unstructured":"Kimura Y, Nakao A, Tamura H, Tanaka S, Takagi H. Clinical and experimental studies of the Limulus test after digestive surgery. Surg Today. 1995;25(9):790\u20134. https:\/\/doi.org\/10.1007\/BF00311454.","journal-title":"Surg Today"},{"issue":"1","key":"4119_CR106","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1034\/j.1600-0676.2001.210110.x","volume":"21","author":"Y Nakatani","year":"2001","unstructured":"Nakatani Y, Fukui H, Kitano H, Nagamoto I, Tsujimoto T, Kuriyama S, et al. Endotoxin clearance and its relation to hepatic and renal disturbances in rats with liver cirrhosis. Liver. 2001;21(1):64\u201370. https:\/\/doi.org\/10.1034\/j.1600-0676.2001.210110.x.","journal-title":"Liver"},{"issue":"1","key":"4119_CR107","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/089419399272755","volume":"12","author":"T Katsuramaki","year":"1999","unstructured":"Katsuramaki T, Suzuki T, Zhu Y, Starzl TE, Matsura S, Todo S. Beta-glucan reflects liver injury after preservation and transplantation in dogs. J Invest Surg. 1999;12(1):39\u201343. https:\/\/doi.org\/10.1080\/089419399272755.","journal-title":"J Invest Surg"},{"issue":"10","key":"4119_CR108","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/j.1432-2277.2012.01529.x","volume":"25","author":"H Lampela","year":"2012","unstructured":"Lampela H, Kosola S, Jalanko H, Pakarinen MP. Galactose half-life is a useful tool in assessing prognosis of chronic liver disease in children. Transpl Int. 2012;25(10):1041\u20139. https:\/\/doi.org\/10.1111\/j.1432-2277.2012.01529.x.","journal-title":"Transpl Int"},{"key":"4119_CR109","first-page":"118","volume":"18","author":"N Tygstrup","year":"1966","unstructured":"Tygstrup N. Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest Suppl. 1966;18:118\u201325.","journal-title":"Scand J Clin Lab Invest Suppl"},{"issue":"1","key":"4119_CR110","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/00000658-200201000-00010","volume":"235","author":"CA Redaelli","year":"2002","unstructured":"Redaelli CA, Dufour JF, Wagner M, Schilling M, H\u00fcsler J, Kr\u00e4henb\u00fchl L, et al. Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg. 2002;235(1):77\u201385. https:\/\/doi.org\/10.1097\/00000658-200201000-00010.","journal-title":"Ann Surg"},{"issue":"4","key":"4119_CR111","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0168-8278(96)80206-6","volume":"25","author":"F Salerno","year":"1996","unstructured":"Salerno F, Borroni G, Moser P, Sangiovanni A, Almasio P, Budillon G, et al. Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. J Hepatol. 1996;25(4):474\u201380. https:\/\/doi.org\/10.1016\/S0168-8278(96)80206-6.","journal-title":"J Hepatol"},{"issue":"12","key":"4119_CR112","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.jpedsurg.2017.08.058","volume":"52","author":"T Mitsunaga","year":"2017","unstructured":"Mitsunaga T, Higashimoto Y, Saito T, Iwai J. Usefulness of 99mTc-DTPA galactosyl human serum albumin liver scintigraphy for evaluating hepatic functional reserve after Kasai procedure. J Pediatr Surg. 2017;52(12):1925\u20139. https:\/\/doi.org\/10.1016\/j.jpedsurg.2017.08.058.","journal-title":"J Pediatr Surg"},{"issue":"7","key":"4119_CR113","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/01.meg.0000219104.40435.43","volume":"18","author":"L Addario","year":"2006","unstructured":"Addario L, Scaglione G, Tritto G, Di Costanzo GG, De Luca M, Lampasi F, et al. Prognostic value of quantitative liver function tests in viral cirrhosis: a prospective study. Eur J Gastroenterol Hepatol. 2006;18(7):713\u201320. https:\/\/doi.org\/10.1097\/01.meg.0000219104.40435.43.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"4119_CR114","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1016\/j.ejrad.2010.11.002","volume":"80","author":"YH Mo","year":"2011","unstructured":"Mo YH, Jaw FS, Ho MC, Wang YC, Peng SSF. Hepatic ADC value correlates with cirrhotic severity of patients with biliary atresia. Eur J Radiol. 2011;80(3):e253\u20137. https:\/\/doi.org\/10.1016\/j.ejrad.2010.11.002.","journal-title":"Eur J Radiol"},{"issue":"10","key":"4119_CR115","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/S0022-3468(03)00500-1","volume":"38","author":"T Ishii","year":"2003","unstructured":"Ishii T, Nio M, Shimaoka S, Sano N, Sasaki H, Kimura D, et al. Clinical significance of 99mTc-DTPA-galactosyl human serum albumin liver scintigraphy in follow-up patients with biliary atresia. J Pediatr Surg. 2003;38(10):1486\u201390. https:\/\/doi.org\/10.1016\/S0022-3468(03)00500-1.","journal-title":"J Pediatr Surg"},{"key":"4119_CR116","unstructured":"Harkins JM, Ahmad B. Anatomy, Abdomen and Pelvis, Portal Venous System (Hepatic Portal System). StatPearls Publishing; 2023."},{"issue":"8","key":"4119_CR117","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s00261-018-1619-8","volume":"43","author":"S Franchi-Abella","year":"2018","unstructured":"Franchi-Abella S, Gonzales E, Ackermann O, Branchereau S, Pariente D, Gu\u00e9rin F. Congenital portosystemic shunts: diagnosis and treatment. Abdom Radiol. 2018;43(8):2023\u201336. https:\/\/doi.org\/10.1007\/s00261-018-1619-8.","journal-title":"Abdom Radiol"},{"issue":"6","key":"4119_CR118","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1442-200X.1991.tb02592.x","volume":"33","author":"S Kagimoto","year":"1991","unstructured":"Kagimoto S, Fujitsuka S, Kinoshita K, Onoue M, Fujisawa T, Yoshioka S. Study to establish normal values for portal vein blood flow in children using a duplex ultrasound system. Pediatr Int. 1991;33(6):693\u20138. https:\/\/doi.org\/10.1111\/j.1442-200X.1991.tb02592.x.","journal-title":"Pediatr Int"},{"issue":"2","key":"4119_CR119","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/00005176-199508000-00014","volume":"21","author":"K Kozaiwa","year":"1995","unstructured":"Kozaiwa K, Tajiri H, Yoshimura N, Ozaki Y, Miki K, Shimizu K, et al. Utility of duplex doppler ultrasound in evaluating portal hypertension in children. J Pediatr Gastroenterol Nutr. 1995;21(2):215\u20139. https:\/\/doi.org\/10.1097\/00005176-199508000-00014.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"4119_CR120","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2165\/00003088-200645100-00005","volume":"45","author":"AN Edginton","year":"2006","unstructured":"Edginton AN, Schmitt W, Willmann S. Development and evaluation of a generic physiologically based pharmacokinetic model for children. Clin Pharmacokinet. 2006;45(10):1013\u201334. https:\/\/doi.org\/10.2165\/00003088-200645100-00005.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"4119_CR121","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1148\/radiol.2292021128","volume":"229","author":"L Annet","year":"2003","unstructured":"Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology. 2003;229(2):409\u201314. https:\/\/doi.org\/10.1148\/radiol.2292021128.","journal-title":"Radiology"},{"issue":"11","key":"4119_CR122","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/lt.24850","volume":"23","author":"C de Magn\u00e9e","year":"2017","unstructured":"de Magn\u00e9e C, Veyckemans F, Pirotte T, Menten R, Dumitriu D, Clapuyt P, et al. Liver and systemic hemodynamics in children with cirrhosis: impact on the surgical management in pediatric living donor liver transplantation. Liver Transpl. 2017;23(11):1440\u201350. https:\/\/doi.org\/10.1002\/lt.24850.","journal-title":"Liver Transpl"},{"key":"4119_CR123","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14563","author":"S Sakamoto","year":"2023","unstructured":"Sakamoto S, Shimizu S, Uchida H, Fukuda A, Kasahara M. Portal vein pressure and flow modulation in pediatric liver transplantation. Pediatr Transplant. 2023. https:\/\/doi.org\/10.1111\/petr.14563.","journal-title":"Pediatr Transplant"},{"issue":"48","key":"4119_CR124","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i48.6046","volume":"16","author":"C Eipel","year":"2010","unstructured":"Eipel C. Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroenterol. 2010;16(48):6046. https:\/\/doi.org\/10.3748\/wjg.v16.i48.6046.","journal-title":"World J Gastroenterol"},{"issue":"36","key":"4119_CR125","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i36.5853","volume":"12","author":"K Sudhamshu","year":"2006","unstructured":"Sudhamshu K. Doppler study of hepatic vein in cirrhotic patients: correlation with liver dysfunction and hepatic hemodynamics. World J Gastroenterol. 2006;12(36):5853. https:\/\/doi.org\/10.3748\/wjg.v12.i36.5853.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"4119_CR126","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v10.i6.915","volume":"10","author":"Z Pan","year":"2004","unstructured":"Pan Z, Wu XJ, Li JS, Liu FN, Li WS, Han JM. Functional hepatic flow in patients with liver cirrhosis. World J Gastroenterol. 2004;10(6):915. https:\/\/doi.org\/10.3748\/wjg.v10.i6.915.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"4119_CR127","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/lt.20380","volume":"11","author":"T Aoki","year":"2005","unstructured":"Aoki T, Imamura H, Kaneko J, Sakamoto Y, Matsuyama Y, Kokudo N, et al. Intraoperative direct measurement of hepatic arterial buffer response in patients with or without cirrhosis. Liver Transpl. 2005;11(6):684\u201391. https:\/\/doi.org\/10.1002\/lt.20380.","journal-title":"Liver Transpl"},{"issue":"2","key":"4119_CR128","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/1742271X221114050","volume":"31","author":"MV Verhagen","year":"2023","unstructured":"Verhagen MV, Kwee TC, de Haas RJ. Hepatic artery and portal vein Doppler ultrasound reference values in children aged 0\u201317\u2009years old. Ultrasound. 2023;31(2):112\u20138. https:\/\/doi.org\/10.1177\/1742271X221114050.","journal-title":"Ultrasound"},{"issue":"7","key":"4119_CR129","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1016\/j.transproceed.2007.07.042","volume":"39","author":"J Bueno","year":"2007","unstructured":"Bueno J, Escart\u00edn A, Balsells J, Margarit C. Intraoperative flow measurement of native liver and allograft during orthotopic liver transplantation in children. Transplant Proc. 2007;39(7):2278\u20139. https:\/\/doi.org\/10.1016\/j.transproceed.2007.07.042.","journal-title":"Transplant Proc"},{"issue":"3","key":"4119_CR130","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jpedsurg.2009.06.015","volume":"45","author":"S Omori","year":"2010","unstructured":"Omori S, Ishizaki Y, Sugo H, Yoshimoto J, Imamura H, Yamataka A, et al. Direct measurement of hepatic blood flow during living donor liver transplantation in children. J Pediatr Surg. 2010;45(3):545\u20138. https:\/\/doi.org\/10.1016\/j.jpedsurg.2009.06.015.","journal-title":"J Pediatr Surg"},{"issue":"6","key":"4119_CR131","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/jmri.26341","volume":"49","author":"EF Cox","year":"2019","unstructured":"Cox EF, Palaniyappan N, Aithal GP, Guha IN, Francis ST. Using MRI to study the alterations in liver blood flow, perfusion, and oxygenation in response to physiological stress challenges: meal, hyperoxia, and hypercapnia. J Magn Reson Imaging. 2019;49(6):1577\u201386. https:\/\/doi.org\/10.1002\/jmri.26341.","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"4119_CR132","doi-asserted-by":"publisher","first-page":"831","DOI":"10.2214\/ajr.181.3.1810831","volume":"181","author":"A Garc\u00eda-Criado","year":"2003","unstructured":"Garc\u00eda-Criado A, Gilabert R, Salmer\u00f3n JM, Nicolau C, Vilana R, Bianchi L, et al. Significance of and contributing factors for a high resistive index on Doppler sonography of the hepatic artery immediately after surgery: prognostic implications for liver transplant recipients. AJR Am J Roentgenol. 2003;181(3):831\u20138. https:\/\/doi.org\/10.2214\/ajr.181.3.1810831.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"4119_CR133","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0168-8278(97)80045-1","volume":"26","author":"GJ Lycklama \u00e0 Nijeholt","year":"1997","unstructured":"Lycklama \u00e0 Nijeholt GJ, Burggraaf K, Wasser MNJM, Schultze Kool LJ, Schoemaker RC, Cohen AF, et al. Variability of splanchnic blood flow measurements using MR velocity mapping under fasting and post-prandial conditions - comparison with echo-Doppler. J Hepatol. 1997;26(2):298\u2013304. https:\/\/doi.org\/10.1016\/S0168-8278(97)80045-1.","journal-title":"J Hepatol"},{"issue":"5","key":"4119_CR134","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.1840080532","volume":"8","author":"RW Schrier","year":"1988","unstructured":"Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rod\u00e9s J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988;8(5):1151\u20137. https:\/\/doi.org\/10.1002\/hep.1840080532.","journal-title":"Hepatology"},{"issue":"4","key":"4119_CR135","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/hep.1840200411","volume":"20","author":"A Maroto","year":"1994","unstructured":"Maroto A, Gin\u00e8s A, Sal\u00f3 J, Cl\u00e0ria J, Gin\u00e8s P, Anibarro L, et al. Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: prognostic value of resistive index. Hepatology. 1994;20(4):839\u201344. https:\/\/doi.org\/10.1002\/hep.1840200411.","journal-title":"Hepatology"},{"issue":"2","key":"4119_CR136","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1148\/radiology.171.2.2649925","volume":"171","author":"JF Platt","year":"1989","unstructured":"Platt JF, Rubin JM, Ellis JH, DiPietro MA. Duplex Doppler US of the kidney: differentiation of obstructive from nonobstructive dilatation. Radiology. 1989;171(2):515\u20137. https:\/\/doi.org\/10.1148\/radiology.171.2.2649925.","journal-title":"Radiology"},{"issue":"2","key":"4119_CR137","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1148\/radiology.187.2.8475308","volume":"187","author":"A Colli","year":"1993","unstructured":"Colli A, Cocciolo M, Riva C, Martinez E. Abnormal renovascular impedance in patients with hepatic cirrhosis: detection with duplex US. Radiology. 1993;187(2):561\u20133. https:\/\/doi.org\/10.1148\/radiology.187.2.8475308.","journal-title":"Radiology"},{"issue":"3","key":"4119_CR138","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/0022-4804(84)90092-1","volume":"36","author":"CS Norris","year":"1984","unstructured":"Norris CS, Barnes RW. Renal artery flow velocity analysis: a sensitive measure of experimental and clinical renovascular resistance. J Surg Res. 1984;36(3):230\u20136. https:\/\/doi.org\/10.1016\/0022-4804(84)90092-1.","journal-title":"J Surg Res"},{"issue":"2","key":"4119_CR139","first-page":"219","volume":"17","author":"D Sacerdoti","year":"1993","unstructured":"Sacerdoti D, Bolognesi M, Merkel C, Angeli P, Gatta A. Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography. Hepatology. 1993;17(2):219\u201324.","journal-title":"Hepatology"},{"issue":"03","key":"4119_CR140","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1055\/s-2008-1027742","volume":"30","author":"A Berzigotti","year":"2009","unstructured":"Berzigotti A, Castaldini N, Rossi V, Magalotti D, Tiani C, Zappoli P, et al. Age dependency of regional impedance indices regardless of clinical stage in patients with cirrhosis of the liver. Ultraschall Med. 2009;30(03):277\u201385. https:\/\/doi.org\/10.1055\/s-2008-1027742.","journal-title":"Ultraschall Med"},{"issue":"8","key":"4119_CR141","doi-asserted-by":"publisher","first-page":"559","DOI":"10.7863\/jum.1999.18.8.559","volume":"18","author":"T Scholbach","year":"1999","unstructured":"Scholbach T. Color Doppler sonographic determination of renal blood flow in healthy children. J Ultrasound Med. 1999;18(8):559\u201364. https:\/\/doi.org\/10.7863\/jum.1999.18.8.559.","journal-title":"J Ultrasound Med"},{"issue":"65","key":"4119_CR142","first-page":"1521","volume":"52","author":"D Dincer","year":"2005","unstructured":"Dincer D, Besisk F, Demirkol O, Demir K, Kaymakoglu S, Cakaloglu Y, et al. Relationships between hemodynamic alterations and Child-Pugh Score in patients with cirrhosis. Hepatogastroenterology. 2005;52(65):1521\u20135.","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"4119_CR143","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1442-200X.2004.01826.x","volume":"46","author":"S Aydo\u011edu","year":"2004","unstructured":"Aydo\u011edu S, Akil I, Akil T, Kabasakal C, Killi R, Mir S, et al. Renal resistive indexes and some renal functions in liver cirrhotic children. Pediatr Int. 2004;46(1):67\u201371. https:\/\/doi.org\/10.1111\/j.1442-200X.2004.01826.x.","journal-title":"Pediatr Int"},{"issue":"4","key":"4119_CR144","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/8756479310374363","volume":"26","author":"NH Abufaddan","year":"2010","unstructured":"Abufaddan NH, Omar NN. Renal hemodynamic changes assessed by color Doppler sonography in children with liver cirrhosis. J Diagn Med Sonogr. 2010;26(4):171\u20137. https:\/\/doi.org\/10.1177\/8756479310374363.","journal-title":"J Diagn Med Sonogr"},{"issue":"12","key":"4119_CR145","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1046\/j.1440-1746.2000.02366.x","volume":"15","author":"M Koda","year":"2000","unstructured":"Koda M, Murawaki Y, Kawasaki H. Renovascular resistance assessed by color Doppler ultrasonography in patients with chronic liver diseases. J Gastroenterol Hepatol. 2000;15(12):1424\u20139. https:\/\/doi.org\/10.1046\/j.1440-1746.2000.02366.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"4119_CR146","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s004670050715","volume":"13","author":"AF Abdallah","year":"1999","unstructured":"Abdallah AF, Bakr AM, El-Haggar M, Amer T. Renal hemodynamic changes in children with liver cirrhosis. Pediatr Nephrol. 1999;13(9):854\u20138. https:\/\/doi.org\/10.1007\/s004670050715.","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"4119_CR147","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1007\/s00431-021-04076-1","volume":"180","author":"P Vijay","year":"2021","unstructured":"Vijay P, Lal BB, Sood V, Khanna R, Alam S. Cystatin C: best biomarker for acute kidney injury and estimation of glomerular filtration rate in childhood cirrhosis. Eur J Pediatr. 2021;180(11):3287\u201395. https:\/\/doi.org\/10.1007\/s00431-021-04076-1.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"4119_CR148","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/S12664-021-01190-8\/TABLES\/4","volume":"41","author":"D Prasad","year":"2022","unstructured":"Prasad D, Sen Sarma M, Yachha SK, Prasad R, Srivastava A, Poddar U, et al. Can we predict early renal impairment in pediatric cirrhosis? Indian J Gastroenterol. 2022;41(2):135\u201342. https:\/\/doi.org\/10.1007\/S12664-021-01190-8\/TABLES\/4.","journal-title":"Indian J Gastroenterol"},{"issue":"6","key":"4119_CR149","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1183\/09031936.00050713","volume":"42","author":"G Kovacs","year":"2013","unstructured":"Kovacs G, Avian A, Olschewski A, Olschewski H. Zero reference level for right heart catheterisation. Eur Respir J. 2013;42(6):1586\u201394. https:\/\/doi.org\/10.1183\/09031936.00050713.","journal-title":"Eur Respir J"},{"issue":"9","key":"4119_CR150","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1056\/NEJM197008272830902","volume":"283","author":"HJC Swan","year":"1970","unstructured":"Swan HJC, Ganz W, Forrester J, Marcus H, Diamond G, Chonette D. Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med. 1970;283(9):447\u201351. https:\/\/doi.org\/10.1056\/NEJM197008272830902.","journal-title":"N Engl J Med"},{"key":"4119_CR151","unstructured":"Patel N, Durland J, Awosika AO, Makaryus AN. Physiology, Cardiac Index. StatPearls Publishing; 2024."},{"key":"4119_CR152","doi-asserted-by":"publisher","unstructured":"Woerlee GM. Cardiac output [Internet]. 1992. p. 188\u201392. https:\/\/doi.org\/10.1007\/978-0-585-28009-7_9.","DOI":"10.1007\/978-0-585-28009-7_9"},{"issue":"4","key":"4119_CR153","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/liv.13589","volume":"38","author":"S M\u00f8ller","year":"2018","unstructured":"M\u00f8ller S, Bendtsen F. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis. Liver Int. 2018;38(4):570\u201380. https:\/\/doi.org\/10.1111\/liv.13589.","journal-title":"Liver Int"},{"issue":"3","key":"4119_CR154","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0163-7258(01)00124-3","volume":"89","author":"L Blendis","year":"2001","unstructured":"Blendis L, Wong F. The hyperdynamic circulation in cirrhosis. Pharmacol Ther. 2001;89(3):221\u201331. https:\/\/doi.org\/10.1016\/S0163-7258(01)00124-3.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"4119_CR155","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/00001574-200305000-00008","volume":"19","author":"G Garcia-Tsao","year":"2003","unstructured":"Garcia-Tsao G. Portal hypertension. Curr Opin Gastroenterol. 2003;19(3):250\u20138. https:\/\/doi.org\/10.1097\/00001574-200305000-00008.","journal-title":"Curr Opin Gastroenterol"},{"issue":"10","key":"4119_CR156","doi-asserted-by":"publisher","DOI":"10.3748\/WJG.V20.I10.2555","volume":"20","author":"M Bolognesi","year":"2014","unstructured":"Bolognesi M, Di Pascoli M, Verardo A, Gatta A. Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis. World J Gastroenterol. 2014;20(10):2555. https:\/\/doi.org\/10.3748\/WJG.V20.I10.2555.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"4119_CR157","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1136\/gut.2006.112177","volume":"57","author":"S Moller","year":"2008","unstructured":"Moller S, Henriksen JH. Cardiovascular complications of cirrhosis. Gut. 2008;57(2):268\u201378. https:\/\/doi.org\/10.1136\/gut.2006.112177.","journal-title":"Gut"},{"issue":"6","key":"4119_CR158","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.jhep.2010.08.001","volume":"53","author":"E Sol\u00e0","year":"2010","unstructured":"Sol\u00e0 E, Gin\u00e8s P. Renal and circulatory dysfunction in cirrhosis: current management and future perspectives. J Hepatol. 2010;53(6):1135\u201345. https:\/\/doi.org\/10.1016\/j.jhep.2010.08.001.","journal-title":"J Hepatol"},{"issue":"2","key":"4119_CR159","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/MPG.0000000000000580","volume":"60","author":"C Celtik","year":"2015","unstructured":"Celtik C, Durmaz O, Oner N, Yavuz T, G\u00f6kce S, Aydogan A, et al. Investigation of cardiomyopathy in children with cirrhotic and noncirrhotic portal hypertension. J Pediatr Gastroenterol Nutr. 2015;60(2):177\u201381. https:\/\/doi.org\/10.1097\/MPG.0000000000000580.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"4119_CR160","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1161\/CIRCULATIONAHA.106.613596","volume":"117","author":"HR Reynolds","year":"2008","unstructured":"Reynolds HR, Hochman JS. Cardiogenic shock. Circulation. 2008;117(5):686\u201397. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.613596.","journal-title":"Circulation"},{"key":"4119_CR161","doi-asserted-by":"publisher","unstructured":"Desai A, Macrae D. cardiovascular physiology in infants, children, and adolescents. Pediatric and congenital cardiology, cardiac surgery and intensive care. 2022. pp. 1\u201316. https:\/\/doi.org\/10.1007\/978-1-4471-4999-6_255-1.","DOI":"10.1007\/978-1-4471-4999-6_255-1"},{"issue":"5","key":"4119_CR162","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jacc.2016.05.043","volume":"68","author":"YNV Reddy","year":"2016","unstructured":"Reddy YNV, Melenovsky V, Redfield MM, Nishimura RA, Borlaug BA. High-output heart failure. J Am Coll Cardiol. 2016;68(5):473\u201382. https:\/\/doi.org\/10.1016\/j.jacc.2016.05.043.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"4119_CR163","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCRESAHA.117.305205","volume":"117","author":"CJ Lavie","year":"2015","unstructured":"Lavie CJ, Arena R, Swift DL, Johannsen NM, Sui X, Lee D, et al. Exercise and the cardiovascular system. Circ Res. 2015;117(2):207\u201319. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.305205.","journal-title":"Circ Res"},{"issue":"10","key":"4119_CR164","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1136\/gut.27.10.1204","volume":"27","author":"A Braillon","year":"1986","unstructured":"Braillon A, Cales P, Valla D, Gaudy D, Geoffroy P, Lebrec D. Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis. Gut. 1986;27(10):1204\u20139. https:\/\/doi.org\/10.1136\/gut.27.10.1204.","journal-title":"Gut"},{"issue":"3","key":"4119_CR165","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/S12072-015-9674-5\/TABLES\/3","volume":"10","author":"K Khemakanok","year":"2016","unstructured":"Khemakanok K, Khositseth A, Treepongkaruna S, Teeraratkul S, Pansrimangkorn W, Leelaudomlipi S, et al. Cardiac abnormalities in cirrhotic children: pre- and post-liver transplantation. Hepatol Int. 2016;10(3):518\u201324. https:\/\/doi.org\/10.1007\/S12072-015-9674-5\/TABLES\/3.","journal-title":"Hepatol Int"},{"issue":"1","key":"4119_CR166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S00246-023-03121-0\/FIGURES\/4","volume":"8","author":"S Baba","year":"2023","unstructured":"Baba S, Ogawa E, Akagi K, Matsuda K, Hirata T, Okamoto T, et al. Hemodynamic and clinical response to liver transplantation in children and young adults POPH patients. Pediatr Cardiol. 2023;8(1):1\u20139. https:\/\/doi.org\/10.1007\/S00246-023-03121-0\/FIGURES\/4.","journal-title":"Pediatr Cardiol"},{"issue":"11","key":"4119_CR167","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/0002-9149(85)90507-7","volume":"55","author":"SC Park","year":"1985","unstructured":"Park SC, Beerman LB, Gartner JC, Zitelli BJ, Malatack JJ, Fricker FJ, et al. Echocardiographic findings before and after liver transplantation. Am J Cardiol. 1985;55(11):1373\u20138. https:\/\/doi.org\/10.1016\/0002-9149(85)90507-7.","journal-title":"Am J Cardiol"},{"issue":"4","key":"4119_CR168","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/PAN.13819","volume":"30","author":"PH Chen","year":"2020","unstructured":"Chen PH, Chan KC, Liao MH, Wu CY. Accuracy of dynamic preload variables for predicting fluid responsiveness in patients with pediatric liver cirrhosis: a prospective study. Paediatr Anaesth. 2020;30(4):455\u201361. https:\/\/doi.org\/10.1111\/PAN.13819.","journal-title":"Paediatr Anaesth"},{"issue":"11","key":"4119_CR169","doi-asserted-by":"publisher","first-page":"617","DOI":"10.23958\/IJIRMS\/VOL07-I11\/1553","volume":"7","author":"MDZ Ersoy","year":"2022","unstructured":"Ersoy MDZ, Ozdemirkan ZA, Zeyneloglu P, Cekmen N, Torgay A, Kayhan Z, et al. Pulse contour cardiac output system monitoring in pediatric patients undergoing orthotopic liver transplantation. International Journal of Innovative Research in Medical Science. 2022;7(11):617\u201321. https:\/\/doi.org\/10.23958\/IJIRMS\/VOL07-I11\/1553.","journal-title":"International Journal of Innovative Research in Medical Science"},{"issue":"1","key":"4119_CR170","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0168-8278(05)80469-6","volume":"20","author":"F Filipponi","year":"1994","unstructured":"Filipponi F, Soubrane O, Labrousse F, Devictor D, Bernard O, Valayer J, et al. Liver transplantation for end-stage liver disease associated with alpha-1-antitrypsin deficiency in children: pretransplant natural history, timing and results of transplantation. J Hepatol. 1994;20(1):72\u20138. https:\/\/doi.org\/10.1016\/S0168-8278(05)80469-6.","journal-title":"J Hepatol"},{"issue":"1","key":"4119_CR171","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/heart.87.1.9","volume":"87","author":"S Moller","year":"2002","unstructured":"Moller S. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart. 2002;87(1):9\u201315. https:\/\/doi.org\/10.1136\/heart.87.1.9.","journal-title":"Heart"},{"issue":"2","key":"4119_CR172","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1136\/gut.49.2.268","volume":"49","author":"F Wong","year":"2001","unstructured":"Wong F, Girgrah N, Graba J, Allidina Y, Liu P, Blendis L. The cardiac response to exercise in cirrhosis. Gut. 2001;49(2):268\u201375. https:\/\/doi.org\/10.1136\/gut.49.2.268.","journal-title":"Gut"},{"issue":"1","key":"4119_CR173","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jhep.2004.09.008","volume":"42","author":"M Torregrosa","year":"2005","unstructured":"Torregrosa M, Aguad\u00e9 S, Dos L, Segura R, G\u00f3nzalez A, Evangelista A, et al. Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol. 2005;42(1):68\u201374. https:\/\/doi.org\/10.1016\/j.jhep.2004.09.008.","journal-title":"J Hepatol"},{"issue":"1","key":"4119_CR174","doi-asserted-by":"publisher","DOI":"10.1186\/S12968-020-00622-2","volume":"22","author":"HM Kim","year":"2020","unstructured":"Kim HM, Kim HK, Lee JH, Lee YB, Park EA, Park JB, et al. Myocardial structural and functional changes in patients with liver cirrhosis awaiting liver transplantation: a comprehensive cardiovascular magnetic resonance and echocardiographic study. J Cardiovasc Magn Reson. 2020;22(1):25. https:\/\/doi.org\/10.1186\/S12968-020-00622-2.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"2","key":"4119_CR175","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0002-8703(92)90656-G","volume":"123","author":"J Parameshwar","year":"1992","unstructured":"Parameshwar J, Keegan J, Sparrow J, Sutton GC, Poole-Wilson PA. Predictors of prognosis in severe chronic heart failure. Am Heart J. 1992;123(2):421\u20136. https:\/\/doi.org\/10.1016\/0002-8703(92)90656-G.","journal-title":"Am Heart J"},{"issue":"7","key":"4119_CR176","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ejhf.268","volume":"17","author":"JL Grodin","year":"2015","unstructured":"Grodin JL, Mullens W, Dupont M, Wu Y, Taylor DO, Starling RC, et al. Prognostic role of cardiac power index in ambulatory patients with advanced heart failure. Eur J Heart Fail. 2015;17(7):689\u201396. https:\/\/doi.org\/10.1002\/ejhf.268.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"4119_CR177","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/J.1399-3046.2008.00909.X","volume":"13","author":"C Arikan","year":"2009","unstructured":"Arikan C, Kilic M, Tumgor G, Levent E, Yuksekkaya HA, Yagci RV, et al. Impact of liver transplantation on rate-corrected QT interval and myocardial function in children with chronic liver disease*. Pediatr Transplant. 2009;13(3):300\u20136. https:\/\/doi.org\/10.1111\/J.1399-3046.2008.00909.X.","journal-title":"Pediatr Transplant"},{"issue":"1","key":"4119_CR178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-97096-8","volume":"11","author":"MM Brito","year":"2021","unstructured":"Brito MM, Miyatani HT, de Alencar Pereira PR, Tannuri ACA, Tannuri U. Evaluation of ventricular systolic function by speckle tracking technique in patients with biliary atresia before and after liver transplantation. Sci Rep. 2021;11(1):1\u201310. https:\/\/doi.org\/10.1038\/s41598-021-97096-8.","journal-title":"Sci Rep"},{"issue":"9","key":"4119_CR179","doi-asserted-by":"publisher","DOI":"10.4240\/WJGS.V15.I9.2021","volume":"15","author":"YL Wu","year":"2023","unstructured":"Wu YL, Li TY, Gong XY, Che L, Sheng MW, Yu WL, et al. Risk factors for myocardial injury during living donor liver transplantation in pediatric patients with biliary atresia. World J Gastrointest Surg. 2023;15(9):2021. https:\/\/doi.org\/10.4240\/WJGS.V15.I9.2021.","journal-title":"World J Gastrointest Surg"},{"key":"4119_CR180","doi-asserted-by":"publisher","unstructured":"Li T, Wu Y, Gong X, Che L, Sheng M, Jia L, et al. Original research: Risk factors for postreperfusion syndrome during living donor liver transplantation in paediatric patients with biliary atresia: a retrospective analysis. BMJ Paediatr Open. 2023;7(1). https:\/\/doi.org\/10.1136\/BMJPO-2023-001934.","DOI":"10.1136\/BMJPO-2023-001934"},{"issue":"6","key":"4119_CR181","doi-asserted-by":"publisher","DOI":"10.1111\/PETR.13237","volume":"22","author":"HS Cho","year":"2018","unstructured":"Cho HS, Kim WJ, Lee BA, Cho J, Shin WJ, Hwang GS. Pretransplant increases in left ventricular volume and mass are associated with QT prolongation during pediatric liver transplantation. Pediatr Transplant. 2018;22(6):e13237. https:\/\/doi.org\/10.1111\/PETR.13237.","journal-title":"Pediatr Transplant"},{"issue":"6","key":"4119_CR182","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/S0041-1345(02)02886-5","volume":"34","author":"F \u00d6z\u00e7ay","year":"2002","unstructured":"\u00d6z\u00e7ay F, Tokel K, Varan B, Sayg\u0131l\u0131 A. Cardiac evaluation of pediatric liver transplantation candidates. Transplant Proc. 2002;34(6):2150\u20132. https:\/\/doi.org\/10.1016\/S0041-1345(02)02886-5.","journal-title":"Transplant Proc"},{"issue":"8","key":"4119_CR183","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.11215","volume":"13","author":"GF Parisi","year":"2013","unstructured":"Parisi GF, Di Dio G, Franzonello C, Gennaro A, Rotolo N, Lionetti E, et al. Liver disease in cystic fibrosis: an update. Hepat Mon. 2013;13(8):e11215. https:\/\/doi.org\/10.5812\/hepatmon.11215.","journal-title":"Hepat Mon"},{"key":"4119_CR184","doi-asserted-by":"publisher","DOI":"10.1148\/rg.230007","author":"CE Morin","year":"2023","unstructured":"Morin CE, Kolbe AB, Alazraki A, Chavhan GB, Gill A, Infante J, et al. Cancer therapy\u2013related hepatic injury in children: imaging review from the Pediatric LI-RADS Working Group. Radiographics. 2023. https:\/\/doi.org\/10.1148\/rg.230007.","journal-title":"Radiographics"},{"issue":"6","key":"4119_CR185","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s40495-021-00266-5","volume":"7","author":"AN Han","year":"2021","unstructured":"Han AN, Han BR, Zhang T, Heimbach T. Hepatic impairment physiologically based pharmacokinetic model development: current challenges. Curr Pharmacol Rep. 2021;7(6):213\u201326. https:\/\/doi.org\/10.1007\/s40495-021-00266-5.","journal-title":"Curr Pharmacol Rep"},{"issue":"1","key":"4119_CR186","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/apt.14078","volume":"46","author":"RA Bhanji","year":"2017","unstructured":"Bhanji RA, Carey EJ, Watt KD. Review article: maximising quality of life while aspiring for quantity of life in end-stage liver disease. Aliment Pharmacol Ther. 2017;46(1):16\u201325. https:\/\/doi.org\/10.1111\/apt.14078.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10308","key":"4119_CR187","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG, Sol\u00e0 E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398(10308):1359\u201376. https:\/\/doi.org\/10.1016\/S0140-6736(21)01374-X.","journal-title":"Lancet"},{"issue":"4","key":"4119_CR188","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/apt.16489","volume":"54","author":"E El-Khateeb","year":"2021","unstructured":"El-Khateeb E, Darwich AS, Achour B, Athwal V, Rostami-Hodjegan A. Review article: time to revisit Child-Pugh score as the basis for predicting drug clearance in hepatic impairment. Aliment Pharmacol Ther. 2021;54(4):388\u2013401. https:\/\/doi.org\/10.1111\/apt.16489.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"4119_CR189","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1053\/he.2000.5852","volume":"31","author":"M Malinchoc","year":"2000","unstructured":"Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PCJ. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864\u201371. https:\/\/doi.org\/10.1053\/he.2000.5852.","journal-title":"Hepatology"},{"issue":"11","key":"4119_CR190","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1001\/jamapediatrics.2018.2541","volume":"172","author":"CCH Chang","year":"2018","unstructured":"Chang CCH, Bryce CL, Shneider BL, Yabes JG, Ren Y, Zenarosa GL, et al. Accuracy of the pediatric end-stage liver disease score in estimating pretransplant mortality among pediatric liver transplant candidates. JAMA Pediatr. 2018;17","journal-title":"JAMA Pediatr"},{"issue":"1","key":"4119_CR191","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/MPG.0000000000003944","volume":"78","author":"FAJA Bodewes","year":"2024","unstructured":"Bodewes FAJA, Freeman AJ, Weymann A, Debray D, Scheers I, Verkade HJ, et al. Towards a standardized classification of the hepatobiliary manifestations in Cystic Fibrosis (CFHBI): a joint ESPGHAN\/NASPGHAN position paper. J Pediatr Gastroenterol Nutr. 2024;78(1):153\u201365. https:\/\/doi.org\/10.1097\/MPG.0000000000003944.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4119_CR192","unstructured":"Cirrhosis - NHS [Internet]. [cited 2024 Feb 26]. Available from: https:\/\/www.nhs.uk\/conditions\/cirrhosis\/."},{"key":"4119_CR193","unstructured":"Tsoris A, Marlar CA. Use Of The Child Pugh Score In Liver Disease. StatPearls Publishing; 2023."},{"key":"4119_CR194","first-page":"1","volume":"1","author":"CG Child","year":"1964","unstructured":"Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964;1:1\u201385.","journal-title":"Major Probl Clin Surg"},{"issue":"2","key":"4119_CR195","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/jhep.2001.22172","volume":"33","author":"P Kamath","year":"2001","unstructured":"Kamath P. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464\u201370. https:\/\/doi.org\/10.1053\/jhep.2001.22172.","journal-title":"Hepatology"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04119-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04119-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04119-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:02:22Z","timestamp":1783674142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04119-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":195,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4119"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04119-y","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}